Postoperative circulating tumor cells predict the benefits of tyrosine kinase inhibitor for hepatocellular carcinoma after transplantation

Ähnliche Einträge

• Recurrence risk prediction models for hepatocellular carcinoma after liver transplantation
  von: Xu Zhang, et al.
  Veröffentlicht: (2024)
• The association between proton‐pump inhibitor use and recurrence of hepatocellular carcinoma after hepatectomy
  von: Chun‐Ting Ho, et al.
  Veröffentlicht: (2024)
• Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma
  von: Hidenori Toyoda, et al.
  Veröffentlicht: (2024)
• Usefulness of preoperative peripheral blood GPC3‐positive circulating tumor cells in subclassification of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma: a retrospective cohort study
  von: Yosuke Namba, et al.
  Veröffentlicht: (2025)
• Optimal treatment strategy and prognostic analysis of salvage liver transplantation for patients with early hepatocellular carcinoma recurrence after hepatectomy
  von: Hao‐Chien Hung, et al.
  Veröffentlicht: (2024)